Hepatitis B DNA vaccine - Guangzhou Baidi BiotechnologyAlternative Names: double-plasmid HBV DNA vaccine - Guangzhou Baidi Biotechnology
Latest Information Update: 17 Feb 2016
At a glance
- Originator Guangzhou Baidi Biotechnology
- Developer Guangzhou Baidi Biotechnology; Guangzhou Pharmaceutical
- Class DNA vaccines; Hepatitis B vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase II Hepatitis B